Total plaque volume and total plaque burden can help find patients who may be closer to suffering a heart attack than they realize. Total plaque volume and total plaque burden can help find patients who may be closer to suffering a heart attack than they realize. | | |
|
Advanced imaging may be able to help certain heart patients avoid the risks and discomfort associated with right heart catheterizations. Advanced imaging may be able to help certain heart patients avoid the risks and discomfort associated with right heart catheterizations. | | |
|
Redo TAVR can be challenging, requiring a significant amount of preprocedural CT planning. This proposed framework was designed to simplify that planning and help interventional cardiologists thrive. Redo TAVR can be challenging, requiring a significant amount of preprocedural CT planning. This proposed framework was designed to simplify that planning and help interventional cardiologists thrive. | | |
|
Former NBA player Muggsy Bogues, who also acted in the 1996 film Space Jam, is one of many athletes now participating in the registry. "I’ve lost too many friends to cardiovascular disease," he said. Former NBA player Muggsy Bogues, who also acted in the 1996 film Space Jam, is one of many athletes now participating in the registry. "I’ve lost too many friends to cardiovascular disease," he said. | | |
|
|
An investigational device could help interventional cardiologists avoid the limitations of drug-eluting stents, according to a new analysis published in JACC. An investigational device could help interventional cardiologists avoid the limitations of drug-eluting stents, according to a new analysis published in JACC. | | |
|
Cardiologist Nathaniel Lebowitz, MD, reviews the latest updates in lipoprotein(a) awareness, testing and drug development. Cardiologist Nathaniel Lebowitz, MD, reviews the latest updates in lipoprotein(a) awareness, testing and drug development. | | |
|
It was another strong quarter for Edwards Lifesciences as the company's TAVR platform continues to gain momentum. The FDA's approval of multiple Edwards valves for the treatment of asymptomatic severe AS represents a potential game-changer for the entire industry. It was another strong quarter for Edwards Lifesciences as the company's TAVR platform continues to gain momentum. The FDA's approval of multiple Edwards valves for the treatment of asymptomatic severe AS represents a potential game-changer for the entire industry. | | |
|
Neil G. Bluhm, a billionaire philanthropist with deep ties to Chicago, has donated an additional $50 million to a high-volume facility that already bears his name. Neil G. Bluhm, a billionaire philanthropist with deep ties to Chicago, has donated an additional $50 million to a high-volume facility that already bears his name. | | |
|
The BioCardia delivery catheter was designed to be used by interventional cardiologists, electrophysiologists or cardiac surgeons. It includes a tiny needle that directly engages with the patient’s cardiac tissue. The BioCardia delivery catheter was designed to be used by interventional cardiologists, electrophysiologists or cardiac surgeons. It includes a tiny needle that directly engages with the patient’s cardiac tissue. | | |
|
|
Shockwave Medical, now a part of Johnson & Johnson MedTech, sits at the top of the IVL market, but things are starting to get more competitive. Boston Scientific gained its own IVL system when it acquired Bolt Medical in 2025. Shockwave Medical, now a part of Johnson & Johnson MedTech, sits at the top of the IVL market, but things are starting to get more competitive. Boston Scientific gained its own IVL system when it acquired Bolt Medical in 2025. | | |
|
The 39-year-old vascular surgeon allegedly killed his ex-wife and her husband on Dec. 30. If convicted, he faces the possibility of life in prison without parole. The 39-year-old vascular surgeon allegedly killed his ex-wife and her husband on Dec. 30. If convicted, he faces the possibility of life in prison without parole. | | |
|
The BENEFIT-HF trial, scheduled to begin enrollment in the months ahead, could significantly increase the number of patients eligible for CVRx's Barostim therapy. The BENEFIT-HF trial, scheduled to begin enrollment in the months ahead, could significantly increase the number of patients eligible for CVRx's Barostim therapy. | | |
|
|
The cyberattack occurred in May 2025, when vendor ApolloMD's network was compromised. The full scope of the breach was reported to HHS on Feb. 10. An infamous ransomware group claimed credit for the attack and threatened to release a data trove on the dark web. It's unclear if any ransom was paid. The cyberattack occurred in May 2025, when vendor ApolloMD's network was compromised. The full scope of the breach was reported to HHS on Feb. 10. An infamous ransomware group claimed credit for the attack and threatened to release a data trove on the dark web. It's unclear if any ransom was paid. | | |
|
Contract negotiations began in September but have stalled. Workers walked off the job at dozens of Kaiser hospitals and clinics on Jan. 26. Now the scope of the strike is expanding and there are no new negotiations scheduled. Contract negotiations began in September but have stalled. Workers walked off the job at dozens of Kaiser hospitals and clinics on Jan. 26. Now the scope of the strike is expanding and there are no new negotiations scheduled. | | |
|
![A majority of medical devices involved in Class I recalls were never required by the U.S. Food and Drug Administration (FDA) to undergo premarket or postmarket clinical testing, according to new research published in Annals of Internal Medicine.[1]](https://cardiovascularbusiness.com/sites/default/files/styles/media_thumbnail/public/2024-09/istock-1209664264.jpg?itok=d9hdApI9)
